This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Silke, B. Articles by King, D. Search for Related Content PubMed PubMed Citation Articles by Silke, B. Articles by King, D. Social Bookmarking                         What's this?

The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability

C. Campbell

D. King

Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, UK

Most antipsychotic drugs have cardiac effects as a consequence of their pharmacological actions. Recently, thioridazine has been subjected to a restricted indications notice and sertindole had its license withdrawn because of concerns about their potential cardiotoxicity. In the development of new atypical agents, heart-rate corrected QT effects are evaluated but it is unclear how predictive these are of clinically significant cardiotoxicity or sudden death. Heart rate variability (HRV) is a potential index of cardiotoxicity which has been found to be decreased following antidepressants and clozapine. We studied acute HRV changes following antipsychotic agents. Sixteen healthy male volunteers received risperidone (4 mg), olanzapine (10 mg), thioridazine (50 mg) or placebo in a randomized cross-over design. Subjective effects and psychomotor function were assayed at 2 h and both linear (summary statistics) and non-linear (scatterplot) measures of HRV were evaluated by continuous electrocardiogram recording over 10 h. Differential effects of single doses of the three antipsychotic drugs on HRV were found, and these were independent of their sedative effects. Olanzapine increased, and thioridazine decreased HRV, while risperidone had no effect. HRV is sensitive to the acute effects of antipsychotics. It may prove to be a reliable index of their potential for cardiotoxicity. Further studies in both healthy volunteers and patients on antipsychotic medication will be valuable.

Key Words: antipsychotics • atypicals • cardiotoxicity • heart rate variability • healthy volunteer

Journal of Psychopharmacology, Vol. 16, No. 4, 355-360 (2002)
DOI: 10.1177/026988110201600410


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Hempel, J. Tulen, N. van Beveren, C. Roder, and M. Hengeveld Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia J Psychopharmacol, August 1, 2009; 23(6): 697 - 707. [Abstract] [PDF]

				C. U. Correll Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes Focus, July 1, 2008; 6(3): 368 - 378. [Abstract] [Full Text] [PDF]